Showing results (131-140 of 499) with videos related to
Sort By:
Pageof 50
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2016
Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic MelanomaLiqiang Xi, Trinh Hoc-Tran Pham, Eden C Payabyab, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2Richard A Morgan, James C Yang, Mio Kitano, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Functional heterogeneity of vaccine-induced CD8(+) T cellsVladia Monsurrò, Dirk Nagorsen, Ena Wang, et al.Science Immunology|January 13, 2019
Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivityMojgan Ahmadzadeh, Anna Pasetto, Li Jia, et al.Melanoma Research|May 5, 2010
Paraneoplastic granulocytosis in metastatic melanomaJeremy L Davis, R Taylor Ripley, Timothy L Frankel, et al.Autism : the International Journal of Research and Practice|June 22, 2017
Self-injurious behaviors in children with autism spectrum disorder enrolled in the Study to Explore Early DevelopmentGnakub Norbert Soke, Steven A Rosenberg, Cordelia Robinson Rosenberg, et al.Head & Neck|October 9, 2018
Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysisSarah Nicole Hamilton, Eric Tran, Eric Berthelet, et al.Soins. Psychiatrie|May 22, 2022
[Management of suicidal crisis in general practice: evaluation of care practices according to patient age]Pierre-Luc Podlipski, Eric Tran, Jan Chrusciel, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene productJianping Huang, Mona El-Gamil, Mark E Dudley, et al.Nature Clinical Practice. Oncology|December 2, 2006
Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?Pawel Muranski, Andrea Boni, Claudia Wrzesinski, et al.Pageof 50